Selexipag
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB11362 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 41 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | pulmonary arterial hypertension associated with congenital heart disease | KG + DL |
| 2 | pulmonary arteriovenous malformation (disease) | KG + DL |
| 3 | pulmonary arterial hypertension associated with schistosomiasis | KG + DL |
| 4 | pulmonary arterial hypertension associated with connective tissue disease | KG + DL |
| 5 | pulmonary arterial hypertension associated with chronic hemolytic anemia | KG + DL |
| 6 | pulmonary arterial hypertension associated with HIV infection | KG + DL |
| 7 | hypotrichosis simplex of the scalp | KG + DL |
| 8 | congenital hypotrichosis milia | KG + DL |
| 9 | diffuse alopecia areata | KG + DL |
| 10 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 11 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 12 | isolated genetic hair shaft abnormality | KG + DL |
| 13 | bilateral parasagittal parieto-occipital polymicrogyria | KG + DL |
| 14 | telangiectasia, hereditary hemorrhagic, | KG + DL |
| 15 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 16 | axial spondylometaphyseal dysplasia | KG + DL |
| 17 | aleukemic mast cell leukemia | KG + DL |
| 18 | hypertrichosis (disease) | KG + DL |
| 19 | dermatofibrosarcoma protuberans | KG + DL |
| 20 | trichomegaly-retina pigmentary degeneration-dwarfism syndrome | KG + DL |
| 21 | amyotrophic lateral sclerosis | KG + DL |
| 22 | Mills syndrome | KG + DL |
| 23 | heart fibrosarcoma | KG + DL |
| 24 | fibroblastic neoplasm | KG + DL |
| 25 | alopecia | KG + DL |
| 26 | acromelanosis | KG + DL |
| 27 | congenital multiple café-au-lait macules-increased sister chromatid exchange syndrome | KG + DL |
| 28 | amyotrophic lateral sclerosis, susceptibility to | KG + DL |
| 29 | conventional fibrosarcoma | KG + DL |
| 30 | amyotrohpic lateral sclerosis type 22 | KG + DL |
| 31 | kidney fibrosarcoma | KG + DL |
| 32 | uterine corpus myxoid leiomyosarcoma | KG + DL |
| 33 | low grade fibromyxoid sarcoma | KG + DL |
| 34 | leukonychia totalis-acanthosis-nigricans-like lesions-abnormal hair syndrome | KG + DL |
| 35 | familial generalized lentiginosis | KG + DL |
| 36 | familial rhabdoid tumor | KG + DL |
| 37 | lower motor neuron syndrome with late-adult onset | KG + DL |
| 38 | anus leiomyosarcoma | KG + DL |
| 39 | lethal arthrogryposis-anterior horn cell disease syndrome | KG + DL |
| 40 | uterine corpus epithelioid leiomyosarcoma | KG + DL |
| 41 | mucosal melanoma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.